СЕРБЕР Марк У. (US),БОСТИАН Кит А. (US),ЛОМОВСКАЯ Ольга (US),ГРИФФИТ Дэвид К. (US),ДАДЛИ Майкл Н. (US)
申请号：
RU2016140347
公开号：
RU2016140347A
申请日:
2016.10.13
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
